Psgl-1 inhibits the incorporation of sars-cov and sars-cov-2 spike glycoproteins into pseudovirions and impairs pseudovirus attachment and infectivity

26Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

P-selectin glycoprotein ligand-1 (PSGL-1) is a cell surface glycoprotein that binds to P-, E-, and L-selectins to mediate the tethering and rolling of immune cells on the surface of the endothelium for cell migration into inflamed tissues. PSGL-1 has been identified as an interferon-γ (INF-γ)-regulated factor that restricts HIV-1 infectivity, and has recently been found to possess broad-spectrum antiviral activities. Here we report that the expression of PSGL-1 in virus-producing cells impairs the incorporation of SARS-CoV and SARS-CoV-2 spike (S) glycoproteins into pseudovirions and blocks pseudovirus attachment and infection of target cells. These findings suggest that PSGL-1 may potentially inhibit coronavirus replication in PSGL-1+ cells.

Cite

CITATION STYLE

APA

He, S., Waheed, A. A., Hetrick, B., Dabbagh, D., Akhrymuk, I. V., Kehn-Hall, K., … Wu, Y. (2021). Psgl-1 inhibits the incorporation of sars-cov and sars-cov-2 spike glycoproteins into pseudovirions and impairs pseudovirus attachment and infectivity. Viruses, 13(1). https://doi.org/10.3390/v13010046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free